Inside a research in breast cancer cells, The mixture of lapatinib, a dual HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented the two HER2 and HER3 phosphorylation induced by INK128 and made synergistic induction of mobile Demise in several HER2-constructive mobile traces proof against trastuzumab and lapatinib. In vivo https://joyceg185sad0.prublogger.com/profile